It is an assumption on my part that the FDA is telling
It is an assumption on my part that the FDA is telling Cytodyn that they do not need to finish either trial completely, but it is based on what Nader said and what Dr J confirmed. They were quite clear that they are presenting the data to the FDA on 6/15 no matter where they are in the trial and that they are not going any further in getting more patients beyond that date, for the M2M trial.
There is no rational reason why they would state this other than they are confident the FDA wants the data ASAP when they have 14 days from injection on the patients on 6/15. Cytodyn could easily state they will just give a readout on 6/15 but will also continue to recruit, they could also not give out the 6/15 date at all. There is some very solid reason for this hard date and I feel it is born out of discussions with the FDA and the data they are already seeing.
Keep in mind, the FDA is watching dozens of drugs for treating covid, only one has years of safety data in over 800 patients showing no side effects, Leronlimab. The FDA's biggest fear is approving a drug that does not work and causes so many terrible side effects that it is worse than the disease. Their day to day job is deciding if the side effects are worse than the benefit on almost every drug they are evaluating in every indication. For them, a drug with this much safety is the one they most want to approve. All they need is data to show it actually works.
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...
Continue Reading
A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...
Continue Reading
FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...
Continue Reading
NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...
Continue Reading
Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...
Continue Reading
A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...
Continue Reading
Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...
Continue Reading
Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....
Continue Reading
Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...
Continue Reading
If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...
Continue Reading
Top 5 Most Recently Viewed Articles
RadNet's Financial Performance in Q2 2025 RadNet, Inc. (NASDAQ: RDNT), a leading provider of high-quality diagnostic imaging services, reported a remarkable performance for the second quarter of 2025. The company achieved a record revenue of $498.2 million, reflecting an 8.4% increase from $459.7 million in the same quarter of 2024. This growth is particularly significant...
Continue Reading
Celsius Network Initiates Fund Distribution for Creditors Celsius Network, LLC has recently taken a significant step by launching an additional fund distribution aimed at its eligible creditors. This initiative comes after the Litigation Administrators successfully allocated over $125 million from the litigation recovery account. The distribution is subject to certain...
Continue Reading
Student Initiative Aims to Combat Climate Change The Dice Well Done Club, formed by students from Taylor Allderdice High School, has made a significant impact by raising over $15,000. This initiative, focused on plugging orphaned oil wells, showcases the determination of youth to combat climate change actively and meaningfully. Encouraged by Community Support The students...
Continue Reading
The Art of Catering: More Than Just Meals When you're in the game of catering, it's not always about tossing a steak on the grill or whipping up a vegan dish. Ya see, it's about making sure everyone at the table feels like they're supposed to be there without missing a beat. That’s where Colin Neville from Madeline’s Catering in Rochester shines, breaking down how to...
Continue Reading
Aker Horizons ASA Announces Full Redemption of Bond Loan In a significant update, Aker Horizons ASA has announced the full redemption of its bond loan. This decision reflects the company's strategic financial management and commitment to its investors. The bond loan, identified under the ISIN NO0010923220, is set to experience an important change in its maturity date and...
Continue Reading